Form 4: ADMA Biologics EVP, CFO Brian Lenz Reports Stock Disposals to Cover Tax Obligations

Sentiment:

SEC Form 4


Brian Lenz, EVP and CFO of ADMA Biologics, reports disposing of shares to cover tax obligations related to vesting restricted stock units (RSUs).

Summary

  • Brian Lenz, the EVP and CFO of ADMA Biologics, filed a Form 4 detailing changes in beneficial ownership.
  • On March 6, 2024, Lenz disposed of 16,677 shares of common stock at a price of $6.12.
  • On March 7, 2024, Lenz disposed of 16,965 shares of common stock at a price of $6.16.
  • These transactions were likely to cover tax obligations associated with the vesting of restricted stock units (RSUs).
  • Following these transactions, Lenz beneficially owns 703,002 shares of ADMA Biologics common stock.
  • The reported holdings include unvested RSUs granted on various dates (February 25, 2021, September 29, 2021, March 7, 2022, and March 6, 2023) that vest quarterly, as well as shares acquired through prior purchases and net settlements of RSUs.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock disposals for tax purposes, a common practice.

Industry Context

Form 4 filings are routine disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. These filings provide transparency to the market regarding insider transactions.

Key Dates

DateDescription
02/25/2021Grant date of 13,750 unvested RSUs that vest quarterly over four years.
09/29/2021Grant date of 123,749 unvested Time-Based RSUs that vest quarterly over two years following December 31, 2022.
03/07/2022Grant date of 68,750 unvested RSUs that vest quarterly over four years.
03/06/2023Grant date of 101,382 unvested RSUs that vest quarterly over four years.
03/06/2024Brian Lenz disposed of 16,677 shares of common stock at $6.12.
03/07/2024Brian Lenz disposed of 16,965 shares of common stock at $6.16.
03/08/2024Date of the Form 4 filing.
12/31/2024Date that 123,749 unvested Time-Based RSUs granted on September 29, 2021, become fully vested.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.